Discontinued — last reported Q3 '25
CVS Health Finance Lease Liabilities decreased by 6.8% to $1.27B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.3%, from $1.30B to $1.27B. Over 5 years (FY 2020 to FY 2025), Finance Lease Liabilities shows an upward trend with a 3.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Higher levels increase the company's long-term leverage and fixed-cost base, while lower levels indicate a more equity-funded or asset-light approach.
The long-term portion of obligations for leases that are classified as financing arrangements, typically involving the e...
Analyzed alongside long-term debt to determine the total contractual leverage and solvency risk of the business.
finance_lease_liabilities| Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.21B | $1.25B | $1.41B | $1.44B | $1.41B | $1.48B | $1.50B | $1.49B | $1.33B | $1.38B | $1.37B | $1.30B | $1.36B | $1.27B |
| QoQ Change | — | +3.6% | +12.6% | +2.1% | -2.2% | +5.5% | +1.1% | -0.4% | -11.3% | +4.1% | -0.4% | -5.7% | +4.8% | -6.8% |
| YoY Change | — | — | — | +19.1% | +12.5% | — | +6.5% | +3.9% | -5.8% | -8.0% | -8.0% | -2.3% | -1.2% | -2.3% |